Bosentan is really an inducer of CYP3A and CYP2C9. As a result plasma concentrations of medicines metabolized by both of these isozymes will probably be lowered when bosentan is coadministered.Bosentan is a selected and competitive antagonist at endothelin receptor forms ETA and ETB. Bosentan has a rather greater affinity for ETA receptors than for